298
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Green Synthesis and Anticancer Evaluation of Novel Chrysin Hydrazone Derivatives

, , ORCID Icon, , &
Pages 176-189 | Received 08 Jul 2021, Accepted 21 Nov 2021, Published online: 08 Dec 2021
 

Abstract

Chrysin, a natural flavonoid, has been investigated for its anticancer biological properties. Antifungal and anticancer properties of hydrazone derivatives have been proven. In this study, eight compounds of substituted Chrysin hydrazine derivatives have been designed, synthesized, and screened against cancerous cell lines, including MCF-7 and HepG-2. All products are reported for the first time. Most compounds exhibited significant cytotoxic activity against selected cell lines. The chemical structures of all compounds were confirmed by spectroscopic methods and elemental analyzes. In vitro evaluation of these synthesized compounds showed most of them have potential antiproliferative activity. Compounds 3e and 3f have shown significant anti-proliferative activity against MCF-7 and HepG-2 cell lines, respectively, compared to Chrysin (P < 0.05). The IC50 values of compounds 3e and 3f were 101.44 and 166.19 µM after 48 h, respectively. Moreover, the compounds 3e and 3f induced significant apoptosis more than Chrysin (P < 0.05). The Results of this research might help the design and synthesis of novel drugs toward developing new antitumor agents for cancer treatment.

Acknowledgments

The authors express appreciation to the Student Research Committee, Jiroft University of Medical Sciences for supporting this investigation.

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.